Johnson & Johnson gained Inlexzo, formerly known as TAR-200, when it acquired privately held Taris Biomedical in 2019. The deal gave J&J a treatment it says could change way the “non-muscle invasive” ...
A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
A dog which was cared for by Chesterfield RSPCA when its owners could not afford life-saving treatment has found a new home.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback